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Abstract: Ubiquitin-proteasome pathways have a crucial role in tumor progression. PSMD4 (Rpn10, 26S proteasome non-ATPase
subunit 4), which is a subunit of the regulatory particle, is a major ubiquitin (Ub) receptor of 26S proteasome. PSMD4 overexpression
has been observed in colon carcinoma, hepatocellular carcinoma, and breast cancer. In this work, we elucidated the effect of hypoxia on
PSMD4 gene expression in prostate cancer cells (PC3). Chemically mimicked hypoxia drastically upregulated PSMD4 gene expression
at both mRNA and protein levels. Transient transfection experiments indicated that all promoter fragments were active in PC3 cells.
Hypoxia increased transcriptional activity of all PSMD4 promoter constructs. EMSA analysis shows that HIF-1a transcription factor
binds to the hypoxia response element (HRE) present within the –98/+52 region of PSMD4 promoter. We also used human umbilical
vein endothelial cell (HUVEC) as a different cell model, in which increased PSMD4 expression was seen only at 24 h. The increased
expression of the PSMD4 level in the PC3 cell line was not parallel to the expression in hypoxic HUVEC.
Key words: PSMD4, hypoxia, transcriptional regulation, prostate cancer, endothelial cells

1. Introduction
In cancer progression, microcommunication between
cancer cells and their microenvironment is important.
When the tumor cells do not get enough oxygen, they
become adaptive to hypoxic conditions by causing various
genetic changes to occur without causing cell death.
Hypoxia has been shown to play a role in the development
of the resistance to radiation and chemotherapeutic
treatment in various tumor types (Zhong et al., 1999;
Harris 2002; Koyasu et al., 2018).
Ubiquitin-proteasome pathways play a crucial role in
the cellular process by regulating the expression of key
proteins involved in oncogenesis and cell cycle progression
(Shen et al., 2013; Chen et al., 2016). 26S proteasomes
catalyze most of the protein degradation in growing
mammalian cells. PSMD4 (Rpn10, 26S proteasome nonATPase subunit 4) and Rpn13, which are 2 subunits of
regulatory particles, are major ubiquitin (Ub) receptors
of 26S proteasome (Collins and Goldberg, 2017). The
PSMD4 gene encodes a ubiquitin-binding protein, S5a,
which serves the 19S regulatory complex and exists in
soluble form in the cytosol. The PSMD4 gene also encodes
ASF (antisecretory factor) and angiocidin. The ASF
protein is similar in sequence to S5a but is quite different
in function. It inhibits intestinal fluid induced by cholera

toxin. Angiocidin is a protein that is overexpressed in
various solid tumors and tumor-capillary endothelial cells.
Angiocidin is antiangiogenic and inhibits tumor growth
(Benaroudj et al., 2003). The carboxy-terminal region of
angiocidin carries 3 additional amino acids, unlike the
other 2 proteins, S5a and ASF (Nelson et al., 2000).
Numerous studies have shown that PSMD4 plays a
significant part in tumor progression. PSMD4 has been
found to be overexpressed in specimens of human colon
cancer (Cheng et al., 2018). PSMD4 is overexpressed and
amplified in breast cancer, correlating with poor survival
rates (Fejzo et al., 2017). However, previous studies have
also shown that nuclear factor kappa B (NF-κB) and
PSMD4 inhibited breast cancer proliferation via epidermal
activation growth factor receptors (Godek et al., 2011).
In colon cancer cells, increased cNrf2 (nuclear factorlike 2) expression promotes colorectal cancer with more
aggressive tumors via upregulating PSMD4 (Lin et al.,
2016). PSMD4 increases cell proliferation via regulation
of the PTEN/Akt pathways in hepatocellular carcinoma
(HCC) cells; in addition, a significant correlation has been
found between HIF1a expression and PSMD4 expression
in HCC patients. These two parameters are a strong
prognosis indicator in HCC (Jiang et al., 2019). In addition,
the silencing of PSMD4 decreased cell proliferation in
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HCC (Chai et al., 2019). Therefore, depending on the type
of tumor, PSMD4 could have different roles.
The purpose of the present study is to identify the
hypoxic regulation of the PSMD4 gene in a prostate cancer
model. Hypoxic conditions were chemically mimicked
in the prostate cell line models (PC3) and normal cells
(HUVEC cell line) and were verified with the HIF1α
mRNA expression level. The cytotoxic effect of hypoxia
was analyzed by MTT assay in both cell lines. The levels
of mRNA and protein of PSMD4 were compared in
normoxic and hypoxic conditions; increased mRNA and
protein expression were detected in both cell models
under hypoxic conditions. The truncated promoter
constructs of the PSMD4 gene were transfected into the
PC3 cell line; similarly, the basal transcriptional activities
of the promoter fragments were increased in hypoxic
conditions (Aydoğan Türkoğlu et al., 2015). The possible
binding sites of HIF in the PSMD4 gene promoter which
were obtained by bioinformatics analysis were also verified
by the EMSA technique. Conclusively, hypoxic conditions
led to upregulation of PSMD4 gene expression by directly
binding of HIF1 transcription factors to the consensus site
of HRE element in the PSMD4 promoter. The data suggest
that PSMD4 could be a novel hypoxia target gene for
prostate cancer therapy.
2. Materials and methods
2.1. Material
Human prostate cell line (PC3) was obtained from Dr.
Kemal Sami Korkmaz, Ege University (EBILTEM) (İzmir,
Turkey) and human umbilical vein endothelial cell line
(HUVEC) was obtained from Dr. Ayhan Bilir, İstanbul
University (İstanbul, Turkey). All tissue culture reagents
were purchased from Invitrogen (Waltham, MA, USA).
The antibodies were purchased from Abcam (Cambridge,
UK), Santa Cruz Biotechnology (Dallas, TX, USA), and
Sigma-Aldrich (St. Louis, MO, USA). Assay reporter kits
(luciferase) were sourced from Clontech (Mountain View,
CA, USA). Cloning primers and EMSA primers were
acquired from Macrogen (Seoul, South Korea).
2.2. Strategies for the cloning of human PSMD4 promoter
PC3 genomic DNA was amplified using primers containing
HindIII and XhoI for upstream region 682 bp of the
translation start site PSMD4 gene (GenBank accession no.
NG_029700.1). Taq DNA Polymerase (Thermo Scientific,
Waltham, MA, USA) was used for the PCR reaction, and
the PCR product was cloned into pGEM-T Easy vector
(Promega, Madison, WI, USA) with a T: A cloning system.
Truncated mutations of the human PSMD4 gene promoter
were prepared using the PCR-based approach. PSMD4
promoter primers sequences are as follows: forward
primer for 682 bp promoter construct, 5’-CTC GAG TAG
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AAA GTC ATT AGC GAT C-3’; forward primer for 326
bp promoter construct, 5’-CTC GAG GGA ATC GAC
ACA GCA ACT-3’; forward primer for 150 bp promoter
construct, 5’-CTC GAG TAC AAC TCC CAG AAC GCA
A-3’; truncated promoter constructs reverse primer, 5’TTC GAA CAT CTT GCC ACC TTC CTC C-3’. All
constructs were sequenced (REFGEN, Ankara) using
pMetLuc sequencing primer to confirm the sequence
integrity. Subsequently, all constructs in pGEMT-easy
were subcloned into pMetLuc reporter vector at the XhoI
and HindIII restriction sites. The 682 bp, 326 bp, and 150
bp of promoter constructs were designated as pMET_
PSMD4_682 (–630/+52), _PSMD4_326 (–274/+52) and
_PSMD4_150 (–98/+52), respectively.
2.3. Cell culture and chemically-mimicked hypoxic conditions
PC3 and HUVEC cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented
with 10% fetal calf serum (FCS) under humidified air
containing 5% CO2 at 37 °C. Cell viability was ensured
by trypan blue exclusion. For both mRNA and protein
analysis, cells were seeded at 2,000,000 cells/25 cm2 flask,
and cells were incubated overnight to allow cells to attach
to wells. A chemical mimetic of hypoxia, CoCl2, was used
to cause a hypoxic response in cells; 150 μM concentration
was determined as the optimum dose for hypoxia. For
hypoxic conditions, PC3 and HUVEC cells were treated
with 150 μM final concentration of CoCl2 for different
time intervals, namely 1, 3, 6, and 24 h (Aydogan Turkoglu
and Kockar, 2016).
2.4. MTT assay
The viability of cells was determined by MTT assays
(Aydogan Turkoglu et al., 2019). Cells were plated onto
a 96-well plate briefly and incubated with 150 μM CoCl2
for 1–24 h. At the end of the incubation times, the cells
were treated by adding MTT 20 μL (5 mg/mL) to each well
and incubated at 37 °C for 4 h. Subsequently, the resultant
medium was discarded and dissolved in formazan
crystals of 100 μL acidified isopropanol (0.04 N HCl).
The absorbance was measured with a spectrophotometer
(Thermo Scientific) at 550 nm. Two independent
experiments were conducted in triplicate.
2.5. Transient transfection of promoter constructs
Various lengths of 5’ truncated PSMD4 promoter constructs
were transiently transfected into PC3 cells by the calcium–
phosphate precipitation method (Aydogan Turkoglu
and Kockar, 2016). SEAP plasmid was used for internal
transfection efficiency control. The secreted luciferase/
SEAP activities in the cell medium were determined using
Ready to Glow secreted luciferase kits (Clontech). The
luciferase activity was normalized to the SEAP value, and
each transfection was repeated at least 3 times. Cells were
treated with 150 μM CoCl2 after transfection for 48 h to
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create a chemically-mimicked hypoxic model; nontreated
cells were included for each assay.

Scientific). Unlabeled cold probe and HIF1α consensus
oligos were employed for a competition assay.

2.6. RNA isolation and quantitative real-time PCR (qRTPCR)
The GeneJET™ RNA Purification Kit was used to
extract total RNA according to the manufacturer’s
recommendation (Thermo Scientific). Revert Aid Reverse
Transcriptase (Thermo Scientific) was used to generate
cDNA. mRNA expression levels of PSMD4, HIF1α, and
human β2 microglobulin (hβ2) were determined with
SYBR Green I Master, (Roche, Basel, Switzerland). The
expression primer sequences for PSMD4 are 5’-GAA
GGT GGC AAG ATG GTG TTG GAA A-3’ and 5’-TCC
TTC TCA TTG TCC TCC ACT GGG CT-3’. hβ2 internal
controls primers are 5’-TTT CTG GCC TGG AGG CTA
TC-’3 and 5’-CAT GTC TCC ATC CCA CTT AAC T-’3.
HIF-1a expression primer sequences are 5’-CCA CCT
ATG ACC TGC TTG GT-’3 and 5’-TGT CCT GTG GTG
ACT TGT CC-’3. A PCR reaction was achieved with 10
µL total volume; by using melting curve analysis, product
specificity verification was done. The results were analyzed
with the Δ-Ct method (Livak and Schmittgen, 2001).

2.9. Statistical analysis
One-way analysis of variance (ANOVA) was used for
statistical analysis in Minitab; P values of 0.05 or less were
accepted for statistical significance of a probability (P).

2.7. Western blot
Preparation of protein samples was performed with a
RIPA buffer, and the samples were size-fractionated under
reducing conditions using 10 % (w/v) polyacrylamide
gels, followed by a transfer step of blotting with
Immobilon-P PVDF membranes (Millipore, Burlington,
MA, USA). Following the blotted membrane incubation
with antibodies, bands were identified by means of
X-ray–sensitive film (Kodak, Rochester, NY, USA) and
an enhanced chemiluminescence detection kit (Pierce
Chemical Co., Dallas, TX, USA). Image J software was
used for quantitative analysis of relative protein expression
of β-Actin and PSMD4 (Aydogan Turkoglu and Kockar
2016; Aydogan Turkoglu et al., 2019).
2.8. Electrophoretic mobility shift assays (EMSA)
EMSA was carried out in accordance with Pierce
manufacturer’s instructions (Thermo Scientific) with
slight modifications (Tokay and Kockar, 2016; Aydemir et
al., 2018). Oligonucleotides used as a probe were 5’GGC
ACC TAC AAC TCC CAG AAC GCA ACG TGG GGG
ACG GAG GCG GAA GCA GCT GGC CAA GCC GAG
GT’3 and 3’CCG TGG ATG TTG AGG GTC TTG CGT
TGC ACC CCC TGC CTC CGC CTT CGT CGA CCG
GTT CGG CTC CA’5. Briefly, the DNA binding reaction
was conducted using DNA-binding buffer and 4 μg PC3
nuclear extracts. Cells were treated with 150 µM CoCl2 for
24 h; these cells were used as a hypoxic nuclear extract.
Samples were placed in 5% native polyacrylamide gel and
subsequently transferred to nylon membranes. Detection
of complexes was performed by autoradiography (Thermo

3. Results
3.1. In silico analysis and cloning of human PSMD4 promoter
Nucleotide sequence databases for PSMD4 cDNA
sequences were investigated in order to identify the
putative promoter region of the PSMD4 gene (GenBank
accession no. NG_029700.1). The PCR-based approach
was used to clone –632/+50 bp of the PSMD4 promoter
region into pGEMT-easy vector using genomic DNA.
Multiple alignment analysis of 800 bp of human, mouse,
and rat PSMD4 promoter sequence showed that the first
200 bp is highly conserved amongst species but there
are some insertions—29bp (–488/–459) in the mouse
promoter and 15 bp (–156/–141) in the rat promoter
region. Pairwise alignment of human PSMD4 and mouse
PSMD4 promoter regions and human PSMD4 and rat
PSMD4 promoter regions show similar identity (52%
identity), although mouse and rat PSMD4 regions are
80% identical (Figure 1A). Transcription factor binding
search was performed to analyze the potential TF binding
elements in the promoter 800 bp PSMD4; the sequence also
presented the occurrence of some potential transcription
factor binding sites for HIF1 (Figure 1B). MatInspector
and EPT programs indicated 4 putative HREs in human
PSMD4 promoter, locations –460, –377, –326, and –79.
Rat and mouse PSMD4 (but not human PSMD4) possess
the common HRE element located at +88 bp.
3.2. Verification of hypoxia and its effects on PC3 and
HUVEC cell proliferation
Hypoxia is an environment in which oxygen is reduced.
The hypoxic microenvironment is a dominant feature of
prostate cancers. There are virtually no studies available
on the hypoxic regulation of the PSMD4 gene in a prostate
cancer model. In addition, in our previous study, the
PSMD4 expression was aberrant in the PC3 and HUVEC
cell lines (Aydoğan Türkoğluet al., 2018). In order to
identify the hypoxic regulation of PSMD4 in PC3 cell
lines, we first confirmed HIF1α overexpression in PC3
and HUVEC cells after inducing hypoxia with CoCl2. For
this, total RNA was isolated from both the cells studied as
a control and the hypoxic group. Real-time PCR analyses
were performed with specific HIF1a primers. With HIF1α
mRNA level in PC3 and HUVEC cells overexpression
control indicated HIF1α expression was perfectly
upregulated in the cells at 1 h, as shown in Figures 2A–2B.
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Figure 1. Bioinformatics analysis human, mouse and rat PSMD4 promoter.
A) Multiple alignments of PSMD4 promoter (–488/+112) were performed. Asterisks in the underneath of the alignment show
conserved residues. (+1) transcription start site, *ATG; translation initiation codon are indicated. B) Human, mouse, and rat
PSMD4 promoters (–700/+100) are aligned, and putative HIF1a binding sites and some consensus sequences are given.

To investigate the effect of hypoxic conditions on
PC3 and HUVEC cell proliferation, the MTT test was
performed. We did not obtain any statistically significant
increasing or decreasing effect of cell proliferation in the
PC3 cell line. A decrease in cell proliferation was observed
with CoCl2 treatment in the HUVEC cell line (Figures
2C–2D).
3.3. Effect of hypoxia on PSMD4 gene regulation
In order to investigate hypoxic regulation on PSMD4
expression, PSMD4 mRNA expression was analyzed
by qRTPCR at different time points. PSMD4 mRNA
expression was increased by hypoxia at an early time point
(1 h). PSMD4 expression at the protein level with hypoxia
was confirmed by Western blot; we also obtained increased
PSMD4 protein level in hypoxia at 1 h (Figures 3A–3B).
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In order to define basal promoter activity, DNA
fragments corresponding to the 682 bp of 5’-flanking
regions of the PSMD4 gene were cloned into the pMetLuc
luciferase reporter vector. Consequently, to determine
the regulatory promoter regions, 3 unique 5’deletion
constructs were produced and cloned into the pMetLuc
reporter plasmid. Figure 4A shows a schematic diagram
of these constructs; specifically, pMET_PSMD4_682
(–630/+52), pMET_PSMD4_326 (–274/+52), and pMET_
PSMD4_150 (–98/+52) Chimeric constructs, which
include the 52 bp of the 5’ UTR region, were transiently
transfected to PC3 cells. Transcription activities were
assessed by dual-luciferase assays. SEAP activity was also
determined from a transfected medium for normalization
of luciferase activity of the constructs. All promoter
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Figure 2. A) To determine HIF1α mRNA levels of PC3. B) HUVEC cells under normoxic (control) and hypoxic
(CoCl2) conditions. Total RNA was isolated and then reverse transcribed and 1 µg cDNA used as a template for realtime PCR. Data are shown as relative expression of HIF1/Hb2 mRNA level. Nontreated cells were used as control. C)
To investigate the effect of hypoxic conditions on cell proliferation PC3. D) HUVEC cells were treated with CoCl2 for
hypoxia. MTT assay was performed as described above. 150 µM CoCl2 was used for hypoxic treatment. Nontreated
cells were used as control.

constructs were active in PC3 cells (Figure 4B). In fact,
a 150-bp fragment of pMET_PSMD4_150 (–98/+52)
was adequate to trigger gene expression in this cell, as
shown in Figure 4B. pMET_PSMD4_326 (–274/+52) and
pMET_PSMD4_150 (–98/+52) promoter basal activities
were stronger than pMET_PSMD4_682 (–630/+52) in
PC3 cells. This suggests the presence of different cis-acting
elements.
3.4. Analysis of HRE element in PSMD4 promoter
Hypoxia response elements (HREs) are cis-acting
elements holding the consensus core sequence 5’-(A/G)
CGT(G/C)(G/C)-3’, and are localized at varying positions
and orientations of the coding region of numerous genes
regulated by hypoxia (Marignol et al., 2005). Based on
in silico analysis, the PSMD4 promoter contains many
putative HIF-1 binding sites: –460, –370, –326, and –79
sites. To investigate the effect of the HIF1α protein on
PSMD4 promoter activity, PC3 cells were transfected
with truncated PSMD4 promoter construct pMET_
PSMD4_682 (–630/+52), pMET_PSMD4_326 (–274/+52)

and pMET_PSMD4_150 (–98/+52), respectively in the
absence or presence of CoCl2.
Overinduction of HIF1α by CoCl2 significantly
increased all of the PSMD4 promoter fragments’ activity
(Figure 4B), but the highest increases were seen in the
promoter construct pMET_PSMD4_326 (–274/+52) and
pMET_PSMD4_150 (–98/+52).
To identify HIF1 in vitro binding to putative PSMD4
promoter recognition sequences, an initial bioinformatics
analysis of PSMD4 promoter for putative HIF1 binding
sites was performed. This analysis identified 4 putative
HREs in the PSMD4 promoter (Figures 1B and 4B). The
luciferase experiments with the promoter fragments
showed us that the hypoxic response was highest in the
smallest promoter fragment (Figure 4B). Therefore, the
first HRE element localized at –79 bp of PSMD4 promoter
was examined in an EMSA assay. EMSA experiments were
performed with biotin-labeled oligonucleotide probes in
the first 150 bp of PSMD4 core promoter region (–104/–
39) and normoxic/hypoxic treated PC3 nuclear extracts
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Figure 3. To investigate PSMD4 mRNA and protein expression in PC3 and HUVEC cell lines under hypoxic conditions,
cells were treated with 150 µM CoCl2. Nontreated cells were used as control. A) PSMD4 mRNA levels were determined
with a qRT-PCR, normalized to hβ2 levels in PC3 cell line. B) PSMD4 protein levels were determined with Western blot,
normalized to β-actin levels in PC3 cell line. C) PSMD4 mRNA levels were taken qRT-PCR, normalized to hβ2 levels in
HUVEC cell line. D) Protein levels were analyzed with Western blot, normalized to β-actin levels in HUVEC cell line.

(Figure 4C). EMSA produced 2 DNA-protein complexes
in normoxic and hypoxic conditions. However, the
binding of Complex 1 in hypoxia-treated nuclear extract
was stronger than the one in normoxic nuclear extract.
Competitive unlabeled probes were used to evaluate
the specificity of the complexes. From the competition
experiment, it was found that the complexes were specific.
Furthermore, biotin-labeled probes binding to PSMD4
DNA were competitively diminished by the addition
of unlabeled consensus HIF1 probe (Figure 4C), which
showed that HIF1 specifically binds to related regions.
3.5. PSMD4 mRNA and protein expression in HUVEC
cell line
We also examined whether the expression of the PSMD4
gene is induced in hypoxic HUVEC cell line. As shown
in Figure 3C, the PSMD4 mRNA expression decreased
as early as 1 h after hypoxic stimulation, as seen in
the quantitative qRT-PCR analysis. Interestingly, the
decreased expression is turned into increased PSMD4
mRNA expression by hypoxia at 3 h, 6 h, and at 24 h. The
production of PSMD4 at the protein level by hypoxia was
confirmed by Western blot; we also obtained decreased
PSMD4 protein levels in hypoxia at 1 h, 3 h, and 6 h (Figure
3D). We only detected the increased PSMD4 protein
level at 24 h. The increased expression of PSMD4 levels
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in the PC3 cell line was not parallel to their expression in
hypoxic HUVEC. This shows cell-type–specific regulatory
elements could regulate PSMD4 promoter activity in PC3
and HUVEC cell lines for promoter constructs. As a result
of this regulation, mRNA and protein levels were changed
in these cell lines.
4. Discussion
To date, researchers have focused on exploiting the hypoxic
nature of tumors in order to design therapeutic strategies
for overcoming hypoxic resistance (Patel and Sant, 2016).
Oxygen-regulated genes are involved in numerous cellular
processes including angiogenesis, glucose homeostasis,
inflammation, and vascular permeability (Weidemann
and Johnson, 2008). Hypoxia-inducible factor-1 (HIF-1)
has been found to be the only directly oxygen-responsive
DNA regulatory element regulating the expression of
oxygen-responsive genes. While inactive in normoxic
circumstances, reduced oxygen tension prompts HIF-1 to
bind to HREs, which are found in the promoters of some
oxygen-responsive genes. HREs contain the consensus
core sequence 5’-(A/G)CGT(G/C)(G/C)-3’, making them
cis-acting elements; they are localized at some positions
and orientations of several hypoxia-regulated gene coding
regions (Marignol et al., 2005).
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Figure 4. A) Schematic representation of truncated promotor constructs. Arrows point the transcription direction
and numbers show the beginning and endpoints of each construct related to the transcription start site (TSS). 682
base pair promoter construct (–632/+50), 326 base pair promoter construct (–276/+50) and 150 base pair promoter
construct (–100/+50) were represented by arrows. Hypoxia response elements (HREs) were indicated by a star in
promoter constructs. B) For the effect of hypoxia on PSMD4 promoter activity in PC3 cells, transient transfection
assay was performed using the truncated promoter constructs. 682 base pair promoter construct in normoxia and
hypoxia activities were indicated by 682 bp N/H abbreviation; 326 base pair promoter construct in normoxia and
hypoxia activities were indicated by 326 bp N/H abbreviation and 150 base pair promoter construct in normoxia and
hypoxia activities were indicated by 150 bp N/H abbreviation. The basal activities of the promoter constructs were used
for comparison. Data is the mean of three individual values ± SD. C) HIF1α protein in vitro binding to the PSMD4
promoter region was examined through EMSA. Competition to probes labeled biotin [−131/−103] were carried out
with unlabeled HIF1a consensus oligonucleotide with a nuclear extract (NE) of PC3. Complexes 1 and 2 were indicated
by C1 and C2.

On the other hand, a dominant feature of prostate
cancers is a hypoxic environment (Deep and Panigrahi,
2015; Lee et al., 2019). The chemically-mimicked hypoxic
environment was formed as described in our previous
study (Aydogan Turkoglu and Kockar, 2016). In our
study, the chemically hypoxic-mimetic agent CoCl2 was
used to create a hypoxic environment. The time intervals
were selected according to the hypoxic response given by
the cells. HIF-1α mRNA level was evaluated for hypoxic
response. Time intervals 1, 3, 6, and 24 h were then

selected in the experimental design. The working principle
of hypoxia is that proline hydroxylases inhibit their activity
by binding to HIF-1α when oxygen is sufficient. The HIF1α protein, which is unable to function, is destroyed in
the proteasome. In the case of CoCl2, CoCl2 specifically
inhibits proline hydroxylases that do not bind to HIF1α and the protein becomes active. It reaches the level of
oxygen deficiency and affects the transcription of hypoxiaregulated genes (Wang et al., 1993, 1995; Yuan et al., 2003;
Torii et al., 2009).
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The ubiquitin–proteasome pathway has a vital part
in cellular processes because it controls the expression of
numerous important proteins involved in oncogenesis and
cell cycle progression (Shen et al., 2013; Chen et al., 2016).
In growing mammalian cells, the great majority of protein
degradation is catalyzed by 26S proteasome. Numerous
studies have found that PSMD4 plays a significant part in
tumor progression. An overexpression of PSMD4 has been
found in human colon cancer (Lin et al., 2016; Cheng et
al., 2018). Furthermore, PSMD4 has been amplified and
overexpressed in breast cancer, and this overexpression
is correlated with low survival rates (Godek et al., 2011;
Fejzo et al., 2017). PSMD4 also increases cell proliferation
in HCC; there is a significant correlation between HIF1
expression and PSMD4 expression in HCC (Jiang et al.,
2019).
Regulation of PSMD4 was studied for the first time in
chemically-induced hypoxic PC3 cells. In our previous
studies, chemically mimicked hypoxia has been successfully
applied in a different cell line (Aydogan Turkoglu and
Kockar, 2016). CoCl2 showed no cytotoxic effect on PC3
cells, but cell death occurred in HUVEC cells. Similarly,
this effect on HUVEC cells has been shown in different
studies. Overexpression of HIF-1 reduced HUVEC cell
viability through autophagy (Wu et al., 2015); HUVEC cell
viability was also significantly affected by CoCl2 doses at
200–400 µM concentrations (Liang et al., 2017).
The hypoxic condition upregulates PSMD4 gene
expression at the mRNA and protein level. The regulation
of transcription and translation can be differently
regulated for the PSMD4 gene in PC3 cells. We think that
the amount of a protein decreases when the transcription
of its encoding gene is reduced, and that there are other
mechanisms regulating the protein’s abundance. For
example, the half-life of the protein could be decreased
due to an induced rate of degradation. Another possibility
is that its mRNA is more preferentially translated during
the condition we analyzed at 1 h. Transcriptional activity

of the PSMD4 gene show powerful basal activity in PC3
cell line. The basal activities of pMET_PSMD4_326
(–274/+52) and pMET_PSMD4_150 (–98/+52) promoter
are stronger than those of pMET_PSMD4_682 (–630/+52)
in PC3 cells. Cell-type–specific regulatory elements
could regulate PSMD4 promoter activity in PC3 cells for
promoter constructs. The longest promoter construct,
pMET_PSMD4_682 (–630/+52), might have a reduced
silencer region. Based on in silico analysis, the PSMD4
promoter consists of 4 putative HIF-1 binding sites: –460,
–377, –326, and –79 sites. Overinduction of HIF-1a by
CoCl2 significantly increased all of the PSMD4 promoter
fragments’ activity (Figure 4B), but the highest responses
are seen in the promoter construct pMET_PSMD4_326
(–274/+52) and pMET_PSMD4_150 (–98/+52). In
recognizing HIF1-dependent regulation of the PSMD4
core promoter, EMSA trials with probes containing biotinlabeled oligonucleotide reside in −131/−103 promoter
were performed in nuclear extracts from PC3 cells. The
results indicated that HIF1a can bind to the corresponding
region in prostate cancer cells.
In conclusion, this study shows that hypoxia regulates
PSMD4 gene expression along with transcriptional activity
regulated by the HIF1a transcription factor. This finding is
important for the development of prostate cancer therapy
that uses hypoxic conditions. Our findings show hypoxiaregulated PSMD4 expression in prostate cancer and give
valuable information for designing novel treatments. The
study delivers new data on PSMD4 regulation by HIF1a in
the prostate cancer cell line.
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